Intramuscular Bioavailability
Intramuscular Bioavailability is the fraction and rate at which a drug administered intramuscularly reaches the systemic circulation in an unchanged form, distinguishing it from bioavailability via other routes by its dependence on local muscle perfusion, injection technique, and physicochemical properties of the formulation.
155
Publications
6.1K
Citations
725
Authors
234
Institutions
Publications per year
2017–2026
14
155
Gerben van ‘t Klooster, Eva Hoeben, Herman Borghys et al. · Antimicrobial Agents and Chemotherapy · 2010 · 186 citations · Full text
1–5 of 155
725
3
h-index
Meridian Medical Systems (United States), United States
3 publications · 80 citations
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 725
234
Meridian Medical Systems (United States)
Aurora, United States
4 h-index
7 publications
180 citations
Pfizer (United States)
New York, United States
4 h-index
13 publications
682 citations
University of Florida
Gainesville, United States
4 h-index
12 publications
296 citations

Radboud University Nijmegen
Nijmegen, The Netherlands
3 h-index
3 publications
84 citations
Utrecht University
Utrecht, The Netherlands
3 h-index
9 publications
655 citations
Auburn University
Auburn, United States
2 h-index
3 publications
41 citations
Service de Santé des Armées
Metz, France
2 h-index
4 publications
119 citations
Orion Corporation (United Kingdom)
Reading, United Kingdom
2 h-index
2 publications
371 citations
1–8 of 234
20 publications · 606 citations
15
h-index
Repository · 14 publications · 379 citations
11
h-index
AAC · 7 publications · 376 citations
7
h-index
6 publications · 197 citations
6
h-index
4 publications · 166 citations
4
h-index
1–5